# Jinchen Shao

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jinchen-shao/

## Facts

| Field | Value |
| --- | --- |
| Citations | 932 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 18 |
| i10-index | 28 |
| Last Known Institution | Shanghai Jiao Tong University |
| OpenAlex ID | https://openalex.org/A5101126685 |
| Works | 48 |

## Researcher papers

- [Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma](https://scholariq.org/papers/multicenter-single-arm-phase-ii-trial-of-camrelizumab-and-chemotherapy-as/)
- [Two-year outcomes of clinical N2-3 esophageal squamous cell carcinoma after neoadjuvant chemotherapy and immunotherapy from the phase 2 NICE study](https://scholariq.org/papers/two-year-outcomes-of-clinical-n2-3-esophageal-squamous-cell-carcinoma-after/)
- [Single-cell profiling reveals the trajectory of FOLR2-expressing tumor-associated macrophages to regulatory T cells in the progression of lung adenocarcinoma](https://scholariq.org/papers/single-cell-profiling-reveals-the-trajectory-of-folr2-expressing-tumor/)
- [Three-arm phase II trial comparing camrelizumab plus chemotherapy versus camrelizumab plus chemoradiation versus chemoradiation as preoperative treatment for locally advanced esophageal squamous cell carcinoma (NICE-2 Study)](https://scholariq.org/papers/three-arm-phase-ii-trial-comparing-camrelizumab-plus-chemotherapy-versus/)
- [Differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal carcinoma with the assistance of next-generation sequencing and immunohistochemistry](https://scholariq.org/papers/differential-diagnosis-of-pulmonary-enteric-adenocarcinoma-and-metastatic/)
- [YAP1-MAML2 Fusion as a Diagnostic Biomarker for Metaplastic Thymoma](https://scholariq.org/papers/yap1-maml2-fusion-as-a-diagnostic-biomarker-for-metaplastic-thymoma/)
- [Clinicopathological Features of ALK Expression in 9889 Cases of Non-small-Cell Lung Cancer and Genomic Rearrangements Identified by Capture-Based Next-Generation Sequencing: A Chinese Retrospective Analysis](https://scholariq.org/papers/clinicopathological-features-of-alk-expression-in-9889-cases-of-non-small-cell/)
- [Clinicopathological characteristics of pulmonary epithelioid hemangioendothelioma: A report of four cases and review of the literature](https://scholariq.org/papers/clinicopathological-characteristics-of-pulmonary-epithelioid/)
- [Identification of <scp><i>NTRK</i></scp> gene fusions in lung adenocarcinomas in the Chinese population](https://scholariq.org/papers/identification-of-scp-i-ntrk-i-scp-gene-fusions-in-lung-adenocarcinomas-in-the/)
- [Targeted next-generation sequencing for analyzing the genetic alterations in atypical adenomatous hyperplasia and adenocarcinoma in situ](https://scholariq.org/papers/targeted-next-generation-sequencing-for-analyzing-the-genetic-alterations-in/)
- [Histological evolution from primary lung adenocarcinoma harboring EGFR mutation to high‐grade neuroendocrine carcinoma](https://scholariq.org/papers/histological-evolution-from-primary-lung-adenocarcinoma-harboring-egfr-mutation/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

## Researcher university

- [Shanghai Jiao Tong University](https://scholariq.org/institutions/shanghai-jiao-tong-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.